Skip to main content
Clinical Trials/NCT05024292
NCT05024292
Recruiting
Not Applicable

Oriental Research Alliance of Acute Ischemic Stroke Given Endovascular Treatment: Technique Feasibility, Safety and Neuroprotective Effects of in Situ Ischemic Postconditioning in Patients Underwent Successful Endovascular Thrombectomy

Shanghai Jiao Tong University Affiliated Sixth People's Hospital2 sites in 1 country160 target enrollmentJanuary 1, 2022
ConditionsIschemic Stroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Stroke
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Enrollment
160
Locations
2
Primary Endpoint
functional independence
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.

Detailed Description

For acute ischemic stroke (AIS) patients with large vessel occlusion in the anterior circulation receieved successful reperfusion, in situ ischemic postconditioning (ISIPC) was performed immediately after successful reperfusion with 5 circules of balloon inflations in the ipsilateral internal carotid artery, each circulation includes inflation lasting 15 seconds followed by 15 seconds of deflation.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
April 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Yueqi Zhu

Associated dean of the radiology

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult (age ≥ 18 to 95 years) patients with an occlusion of the internal carotid artery or M1 or M2 segment of the middle cerebral artery,;
  • Patients with a score of at least 6 on the National Institutes of Health Stroke Scale (NIHSS) at admission and a score of 0 or 1 on the modified Rankin scale before the onset of stroke;
  • Patients with a score of at least 6 on the Alberta Stroke Program Early CT score (ASPECTS) value;
  • Baseline multimodal-CT imaging, including NCCT, CTA and CTP, performed at the trial-site hospital
  • The modified thrombolysis in cerebral infarction (mTICI) scale 2b to 3 achieved in the infarct-related artery after the last thrombectomy attempt

Exclusion Criteria

  • Stoke of large artery atherosclerotic origin or other determined factors (such as dissection) or tandem occlusion;
  • Patients underwent rescue angioplasty or stenting after thrombectomy

Outcomes

Primary Outcomes

functional independence

Time Frame: 3 month

mRS 0-2

Secondary Outcomes

  • excellent functional independence(3 month)
  • early therapeutic response(on day 5, 6, or 7 of hospitalization or at discharge if it occurred before day 5)
  • Mortality(3 month)
  • hemorrhagic transformation(24 hours after treatment)
  • Symptomatic intracerebral hemorrhage (sICH)(24 hours after treatment)
  • malignant infarction(24 hours after treatment)

Study Sites (2)

Loading locations...

Similar Trials